Download Technology Capabilities
300+ highly skilled employees in multidisciplinary teams
Offices in Germany, India, USA
20+ global clients including many Big Pharma
in Data Protection
machine learning & AI framework & blockchain technology
300TB+, adding more each week
100+ patent applications including 10 grants
Cutting edge technology to build reliable, secure & compliant applications
“Our Vision is to be recognized by our customers as leading provider of Artificial Intelligence based products offering best in class data crawling, aggregation, analysis and visualization solutions.”
“We enable customers to succeed in a competitive market by delivering real time access to full picture of relevant data.
We continuously develop our products based on Artificial Intelligence to enable broader, deeper and faster insights and best found decision making.”
CHAIRMAN, SUPERVISORY BOARD
Martin Korbmacher is the founder and Managing Partner of Event Horizon Capital & Advisory GmbH. Event Horizon is a Corporate Finance Boutique as well as an investment vehicle.
After studying Mathematics, Physics, and Computer Science, he has spent more than 20 years in various Senior Executive functions in global investment banks in Frankfurt, London, and New York. Starting out in Fixed Income Trading for JP Morgan, he was the Global Head of Fixed Income and the Global Head of Equities for Dresdner Kleinwort finishing of his banking career at Credit Suisse as the Head of the Investment Banking Division for Germany and Austria.
In addition, he holds the position as the Chairman of the supervisory board of the publicly listed flatex AG, Chairman of Starmind AG in Zurich and is a member of the supervisory board of German Startups Group Berlin GmbH & Co. KGaA.
MEMBER, SUPERVISORY BOARD
Hans-Christian Semmler is Managing Director of Frankfurt based, technology focused, HCS Beteiligungsgesellschaft mbH, founded in 2003. Since 2014, he is also a member of the supervisory board of AGO AG Energie + Anlagen.
From 2003 to 2010, he held the position of CEO at Haupt Pharma AG, a contract manufacturer and developer of pharmaceutical products with various company sites in Europe and Japan. From 1995 to 2001, he was CFO of Vossloh AG, one of the world’s leading railway engineering companies. He was also a member of the supervisory board of VAE AG. Prior to this, he worked in investment banking in Deutsche Bank.
Hans-Christian Semmler studied law and business administration in Kiel, Vienna and Passau and is authorized to practice as a lawyer.
MEMBER, SUPERVISORY BOARD
Klaus Engel, married, was born on April 21, 1956 in Duisburg, Germany. From 2009 to 2017 he was Chief Executive Officer of Evonik Industries AG, a public listed, leading Specialty Chemical company with about 35000 employees and global sales of around 15 billion euros. In 1984 he received a PhD in Organic Chemistry from Ruhr-University Bochum. Later on he assumed various senior executive management positions in R&D, production, marketing and strategic planning at Chemische Werke Hüls/Marl, VEBA AG, Düsseldorf and Stinnes AG, Mülheim an der Ruhr before he joined Brenntag AG/Mülheim, the global leader in Chemical Distribution, in 2001 as Chief Executive Officer. In 2006 he became Member of the Board of RAG AG, Essen and CEO of Degussa AG, a predecessor company of Evonik Industries.
From 2010-2012 Klaus Engel was President of the Association of the Chemical Industry (VCI) and Vice-President of the German Industry (BDI) at the same time. On behalf of the Mayor of Shanghai he joined his International Business Leadership Advisory Council from 2012-2017. Since 2011 he is Member of the Supervisory Board of National-Bank, Essen and since 2018 Member of the Advisory Board of Ruhr-University, Bochum. Klaus Engel’s leadership in civil society was honoured in 2011 by the Fasel-Preis for Social market economy and in 2014 by the Federal Cross of Merit.
He is honorary professor at University of Duisburg/Essen and Member of the Board of trustees of Bonner Akademie für angewandte Politik at University of Bonn.
MEMBER, SUPERVISORY BOARD
Florian Brand, is Co-Founder and CEO of ATAI Life Sciences AG, a German-based, internationally active biotech company, investing in and acquiring promising therapeutics focusing on mental well-being. He is also a member of the Board of Directors for Perception Neuroscience since November 2018, and for COMPASS Pathways since January 2019. Their ultimate mission is to help people live healthier and happier lives by leveraging cutting-edge scientific research and technology.
From October 2013 to June 2018, Florian was Managing Director for Springlane GmbH, where he was responsible for organizational development, international marketing and team leadership. Prior to this, he worked as a Consultant at a specialized Neurological Clinic in Königstein, Germany, from January 2007 to January 2016.
Florian Brand studied Economics at the Ludwig-Maximilians Universität München (2007-2011) and at The Faculty of Business and Economics of the University of Lausanne (2010-2011); he obtained his Master’s degree in Management from ESCP Europe in 2013.
At Innoplexus, we believe in giving back to the society by leveraging our strengths to the benefit of our local communities: sharing our knowledge, expertise and capabilities, and investing time in giving back to the communities in which we operate.
Innoplexus is guided by a deep commitment to good corporate citizenship through our employees’ donation of time and skills. We are supporting and encouraging our employees to volunteer at a wide range of organizations worldwide.
Sponsored by the company’s leadership, each and every Innoplexus employee has the opportunity to contribute their time, knowledge and skills towards community activity on a weekly, monthly and yearly basis.
One of our projects is an early learning support in Pune. Innoplexus employees chose to promote excellence in education among children with emphasis on bridging gaps between various socio-economic groups towards academic and personal excellence with the long-term vision of their integration into higher education and advanced careers.
Innoplexus employees volunteer in a variety of activities to provide the children academic reinforcement and positive role modelling.
In the last couple of years, data science has continued to make rapid advances, particularly in the fields of machine learning and deep learning. It is predicted that the demand for data scientists and data engineers alone will grow by 39 percent until 2020. It is challenging to recruit people skilled at machine learning, big data, and data science, not only because of the limited talent available but also because of the rapidly evolving landscape.
Therefore, we at Innoplexus collaborate with the talents of tomorrow with an educational programme to encourage out of the box thinking. We have a cooperation with the Gymnasium Riedberg in Frankfurt, Germany. The bilingual school has a focus on natural sciences and languages. Innoplexus experts give virtual lessons in e.g. machine learning and insights into the practical application of cutting-edge AI technologies. This is a two-month programme, with 6 sessions of 1.5 hours each (total 9 hours), followed by an assignment/ minor project.
With our membership in the German Association “Bundesverband für Künstliche Intelligenz”, we support the socially responsible use of AI technologies. Promoting research, development, and the implementation of humane AI technologies as well as educating society and industries on opportunities and risks play an important role.
The KI quality seal of the KI Bundesverband e.V. pursues the goal of a people-centered and human-beneficial use of Artificial Intelligence. By defining and adhering to an overarching understanding of values and processes, the seal ensures ethical service and product development. In the center stand quality criteria ethics, impartiality, transparency, as well as security and data protection. For each quality criterion, necessary measures are to be recorded. At the time of introduction, the seal includes a self-declaration which is signed by Innoplexus.